Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

infarction/nutukimas

Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 3921 rezultatus
BACKGROUND With increasing rates of obesity and its link with cardiovascular disease, there is a need for better understanding of the obesity-outcome relationship. This study explores the association between categories of obesity with treatment times and mortality for patients experiencing

Obesity without metabolic disorder and silent brain infarcts in aneurologically healthy population.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Obesity without metabolic disorder [Ob(+)MD(-)] is a unique subcategory of obesity where individuals are protected from the obesity-related complications. Although conflicting clinical outcomes have been reported, there has been no study of the effects of Ob(+)MD(-) on cerebrovascular
BACKGROUND The Fas apoptotic pathway has been implicated in type 2 diabetes and cardiovascular disease. Although a polymorphism (rs7138803; G > A) near the Fas apoptotic inhibitory molecule 2 (FAIM2) locus has been related to obesity, its association with other cardiovascular risk factors and
Hypertrophic cardiomyopathy is associated with poor prognosis. In our previous study, it has been reported that patients with acute myocardial infarction and hypertrophic cardiomyopathy exhibited worse long-term outcomes than those with acute myocardial infarction without hypertrophic

Impact of obesity on results after primary angioplasty in patients with ST segment elevation acute myocardial infarction.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND Obesity is an important risk factor for the development of diabetes, hypertension, coronary disease, left ventricular dysfunction, stroke and cardiac arrhythmias. Paradoxically, previous studies in patients undergoing elective coronary angioplasty showed a reduction in hospital and

Body Mass Index and Outcome of Acute Myocardial Infarction - Is There an Obesity Paradox?

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND Although there have been some studies focusing on the relationship between body mass index (BMI), coronary artery disease (CAD) and acute coronary syndrome, the clinical effects of BMI on outcomes after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction
OBJECTIVE To determine the association between obesity and outcomes in post-acute myocardial infarction (AMI) patients with systolic heart failure (HF). RESULTS Of the 6632 Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) participants, 6611 had data on
BACKGROUND There is little known about the influence of obesity on ventricular electrical remodelling after myocardial infarction. The aim of our study was to assess the relationship between body mass index (BMI) and the primary outcome of inducible-VT and the secondary outcome of all-cause
Background: Obesity is a coronary risk factor associated to myocardial infarction although waist to-hip-ratio has shown higher predictive power. Objective: The aim of this study was a Receiver Operating Characteristic anthropometric analysis in infarcted males to identify the strength of association
OBJECTIVE Recently, the prognostic value of N-terminal brain natriuretic peptide (NT-proBNP) in acute coronary syndrome has been demonstrated in many studies. However, NT-proBNP levels are influenced by various factors such as sex, age, renal function, heart failure severity, and obesity. NT-proBNP
BACKGROUND Cardiovascular events (stroke or myocardial infarction) are often associated with poorer prognosis in younger, compared with older individuals. We examined the associations between prepregnancy obesity and the risks of myocardial infarction and stroke in young, healthy women. RESULTS All
BACKGROUND Obesity is an established risk factor for coronary heart disease. However, data on the relationship between obesity and prognosis following acute myocardial infarction (AMI) are still lacking in Japan. RESULTS In the present study, 1,458 AMI patients were enrolled in the AMI-Kyoto

Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The association between abdominal obesity and recurrent atherosclerotic cardiovascular disease after myocardial infarction remains unknown.The purpose of this study was to investigate the prevalence of abdominal obesity and its association with recurrent

Obesity and the metabolic syndrome in patients with acute myocardial infarction.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The metabolic syndrome (MS) is a novel risk factor for coronary artery disease. The International Diabetes Federation (IDF) re-definition of MS lists obesity as the essential feature of MS. We determined the presence of MS by this obesity-centric definition in 107 consecutive patients with acute

High prevalence of obesity in young patients with ST elevation myocardial infarction.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND There is growing concern about increasing rates of obesity in young people, and increasing ST elevation myocardial infarction (STEMI) at a younger age. There are only a few studies performed to study the risk factors in STEMI among young populations. METHODS Retrospective chart reviews on
Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge